Monthly Newsletter

The Drug Discovery USA Congress, 3rd - 4th October 2016 in San Diego, USA, brings together a host of over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions to discuss recent developments in the industry and debate the best strategies and solutions to improve drug discovery going forward.

This Congress brings together researchers seeking new techniques to manage complex early stage discovery portfolios and for library optimisation. Our renowned speakers will explore peptide drug discovery, strategies for target selection and incorporating genomic technologies into discovery research though 40 presentations focused on the key issues in drug discovery and medicinal chemistry.

2016’s event features 4 interactive streams:

• Target Based Discovery

• Screening & Assays: Enabling Technologies

• Discovery Chemistry & Drug Design

• Supporting Innovation: Translational Approaches & Informatics Tools

Our delegates will have the unique opportunity to hear from those working at the forefront of innovation with informatics tools in which they will explore new data analysis and integration platforms, as well as ideas for efficient data exchange and pre-competitive collaboration. The congress will also host discussions about the latest research in the discovery chemistry field, with exciting case studies covering computational tools for gene editing and drug design as well as fragment based drug discovery case studies.

For further information click here